168 related articles for article (PubMed ID: 35986972)
1. Novel approaches for treatment of endometrial carcinoma.
Garg V; Jayaraj AS; Kumar L
Curr Probl Cancer; 2022 Oct; 46(5):100895. PubMed ID: 35986972
[TBL] [Abstract][Full Text] [Related]
2. Immune check-point in endometrial cancer.
De Felice F; Marchetti C; Tombolini V; Panici PB
Int J Clin Oncol; 2019 Aug; 24(8):910-916. PubMed ID: 31049759
[TBL] [Abstract][Full Text] [Related]
3. Management of endometrial cancer.
Fowler W; Mutch D
Womens Health (Lond); 2008 Sep; 4(5):479-89. PubMed ID: 19072487
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Treatment of Advanced, Persistent or Metastatic Endometrial Cancer: State of the Art and Perspectives of Clinical Research for the Special Issue "Diagnosis and Management of Endometrial Cancer".
Gadducci A; Cosio S
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944775
[TBL] [Abstract][Full Text] [Related]
5. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K; Kucukali T
Int J Gynecol Cancer; 2002; 12(5):448-53. PubMed ID: 12366661
[TBL] [Abstract][Full Text] [Related]
6. Identification of
Beinse G; Rance B; Just PA; Izac B; Letourneur F; Saidu NEB; Chouzenoux S; Nicco C; Goldwasser F; Batteux F; Durdux C; Chapron C; Pasmant E; Leroy K; Alexandre J; Borghese B
Int J Gynecol Cancer; 2020 May; 30(5):640-647. PubMed ID: 32169874
[TBL] [Abstract][Full Text] [Related]
7. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for endometrial cancer: unproven.
Creutzberg CL
Int J Gynecol Cancer; 2010 Oct; 20(11 Suppl 2):S60-3. PubMed ID: 20975364
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes and patterns of failure in women with stage IIIC
Lee JK; Mahan M; Hanna RK; Elshaikh MA
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
[TBL] [Abstract][Full Text] [Related]
10. Systemic therapy for the treatment of endometrial cancer.
Neri M; Peiretti M; Melis GB; Piras B; Vallerino V; Paoletti AM; Madeddu C; Scartozzi M; Mais V
Expert Opin Pharmacother; 2019 Nov; 20(16):2019-2032. PubMed ID: 31451034
[No Abstract] [Full Text] [Related]
11. Evolution of adjuvant treatment in endometrial cancer-no evidence and new questions?
Marnitz S; Köhler C; Gharbi N; Kunze S; Jablonska K; Herter J
Strahlenther Onkol; 2018 Nov; 194(11):965-974. PubMed ID: 30112692
[TBL] [Abstract][Full Text] [Related]
12. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitors in endometrial cancer.
Gómez-Raposo C; Merino Salvador M; Aguayo Zamora C; García de Santiago B; Casado Sáenz E
Crit Rev Oncol Hematol; 2021 May; 161():103306. PubMed ID: 33839243
[TBL] [Abstract][Full Text] [Related]
14. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
15. Current recommendations and recent progress in endometrial cancer.
Brooks RA; Fleming GF; Lastra RR; Lee NK; Moroney JW; Son CH; Tatebe K; Veneris JL
CA Cancer J Clin; 2019 Jul; 69(4):258-279. PubMed ID: 31074865
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
[TBL] [Abstract][Full Text] [Related]
17. Management of early-stage endometrial cancer.
Lu KH
Semin Oncol; 2009 Apr; 36(2):137-44. PubMed ID: 19332248
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the endometrium.
Southcott BM
Drugs; 2001; 61(10):1395-405. PubMed ID: 11558829
[TBL] [Abstract][Full Text] [Related]
19. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
